Explanipedia

S128 Exploring the behaviour of mesothelioma in a post hoc analysis from the time 1 trial Open

RM Mercer, J. Macready, H Jeffries, N Speck, NI Kanellakis , et al. · 2017

Introduction Malignant Pleural Mesothelioma (MPM) is the only malignancy which develops primarily in the pleural space and is a common cause of a malignant pleural effusion (MPE). MPE associated with MPM is managed similarly to any other m…

P233 Thoracic ultrasonography as a predictor of pleurodesis success in malignant pleural effusion Open

JP Corcoran, RJ Hallifax, Ahmed Yousuf, RM Mercer, Rachelle Asciak , et al. · 2017

Background Over 50 000 patients with malignant pleural effusion (MPE) are seen annually in the UK. The majority develop recurrent symptomatic disease requiring definitive treatment. MPE is most frequently managed with talc slurry pleurodes…

P239 Is a pleural on-call service beneficial? Open

Rachelle Asciak, Rob Hallifax, RM Mercer, J P Corcoran, John Wrightson , et al. · 2017

Aim To audit the pleural on-call service referrals and outcome. Method Our unit instituted the provision of a “pleural phone” and pleural email service as a central point of contact for pleural related questions, both internally for our l…

S129 Does inflammation predict successful pleurodesis? a post hoc analysis from the time 1 trial Open

RM Mercer, J. Macready, H Jeffries, N Speck, Nikolaos I. Kanellakis , et al. · 2017

Introduction Malignant pleural effusions are a common complication of advanced malignancy, have a poor prognosis and have a significant impact on quality of life. Treatment strategies include chest drain and pleurodesis, or insertion of an…

RM Mercer YOU? Author Swipe